SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.690+5.0%Dec 2 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: HardToFind6/8/2022 2:15:42 AM
  Read Replies (1) of 12856
 
I'm guessing NNVC's MktCap is now below the cost of the facility in Shelton, CT.

May 16, 2022: "NanoViricides expects filing a clinical trial application for COVID-19 to occur relatively soon, although the timelines are outside the company's control."

Hmmm...filing a clinical trial application...timelines are outside the company's control.

The story never changes...not our fault...out of our control...blame the cabal of naked shortsellers. The company specializes in perfecting their victim mentality and proving their inability to control (or even influence) the future of their drug development programs.

Total losers.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext